Menu
Health Care Resource Centers (HCRC) provides medication-assisted treatment (MAT) and substance use counseling for individuals living with opioid addiction. Our MAT programs offer methadone treatment, which has been the gold standard in opioid addiction care since the mid-1960s. We also offer buprenorphine treatment (with Suboxone and other products) at select locations. Our patients receive treatment plans tailored specifically to meet their individual needs, ensuring a personalized and comprehensive approach to their recovery.
Medication-assisted treatment with methadone is the gold standard for opioid addiction when supported by counseling.
Office-based buprenorphine treatment (Suboxone) is offered in select locations, providing treatment in a setting similar to a physician’s office.
Opioid addiction treatment with Health Care Resource Centers (HCRC) includes counseling as an essential part of a patient’s treatment plan.
As permitted by the patient, treatment verification and reporting to meet various legal obligations, such as: probation, parole, family court. Services such as these tend to have and added benefit to a person’s legal circumstances.
For women who are pregnant or breastfeeding, MAT programs can also lead to better health outcomes for both the mother and baby. The longer you remain in MAT, the more you will be able to manage your dependency and make progress toward your recovery.
Methadone and buprenorphine are both medications used to help manage opioid withdrawal symptoms and support recovery. These medications make the process of stopping opioid use more manageable and reduce cravings, helping individuals regain control over their lives.
Methadone is a long-acting opioid that works by activating opioid receptors in the brain to a controlled extent. This helps reduce withdrawal symptoms and cravings without producing the “high” associated with other opioids. It is administered at carefully monitored doses by healthcare professionals to ensure safety and effectiveness.
Buprenorphine, on the other hand, is a partial opioid agonist, which means it activates opioid receptors in the brain but to a much lesser degree than methadone or other opioids. This “ceiling effect” limits its potential for misuse, lowers the risk of overdose, and reduces cravings and withdrawal symptoms.
Both methadone and buprenorphine are proven to help people stay in treatment longer, reduce illicit opioid use, and improve overall quality of life. They are prescribed as part of a comprehensive treatment plan to help you gradually regain stability and work towards long-term recovery.
Medication-assisted treatment (MAT) is only one part of addressing substance use disorders (SUDs); counseling is also a crucial component. Behavioral therapies need to be evidence-based and supported by clinical research to ensure they are effective for treating SUDs. Some therapies that meet these criteria include:
Decreased use of opioids and other substances reduces the risks of overdose and death, social stresses, financial problems, legal issues and infectious disease. We encourage and educate patients on overdose prevention with use of Narcan (naloxone), safe injection techniques, drug testing and safe sex practices.
When you arrive at Health Care Resource Centers, we’ll start with a comprehensive assessment to understand your substance use and make an accurate diagnosis. Based on this, we’ll create a personalized treatment plan to address your specific needs. If your provider determines that methadone or buprenorphine is the right option, you’ll be prescribed an initial dose. Your provider will monitor how well you tolerate the first dose and adjust the dosage if needed, aiming for the level that makes you most comfortable. In most cases, this process takes as long as 14 days for methadone, while the correct dose for buprenorphine is usually found more quickly.
Tapering off medication may be an option after significant progress in recovery. Your medical provider and counselor will guide you to determine if and when it’s the right step. A strong support system and active engagement in treatment are essential for success.
During tapering, your provider will offer clear instructions for gradually reducing your dose, while our team monitors withdrawal symptoms, cravings, and your ability to continue counseling effectively.
